15 Set-It-and-Forget-It Stocks to Buy According to Analysts

11. Johnson & Johnson (NYSE:JNJ)

Analyst Upside: 12.72%

Number of Hedge Fund Holders: 91

Johnson & Johnson (NYSE:JNJ) ranks among the best set-it-and-forget-it stocks to buy. Asad Haider, a Goldman Sachs analyst, remained optimistic about Johnson & Johnson (NYSE:JNJ) shares, rating it as a Buy on June 5. The analyst noted several factors that lead to the update.

Similar to its industry peers, the company demonstrates a proactive approach to navigating regulatory environments by participating in policy discussions with the administration. This could result in positive outcomes in areas such as 340B reform and PBM.

Johnson & Johnson’s innovation skills are further demonstrated by the company’s pharmaceutical pipeline achievements, including the encouraging Carvykti data and the expected approval of TAR-200. The company’s strategic move from Stelara to Tremfya and its investments in commercial fulfillment further highlight its commitment to preserving a dominant market position.

Johnson & Johnson (NYSE:JNJ) is a notable name in the healthcare industry, which includes sub-sectors like pharmaceuticals, medical equipment, and consumer health products. The company is known for creating medications to treat a variety of conditions and diseases, including cancer, diabetes, and HIV/AIDS.